Zwart, Bastiaan http://orcid.org/0000-0001-7431-7586
Claessen, Bimmer E. P. M.
Damman, Peter
Woudstra, Pier
Vink, Maarten A.
Balder, J. Willem
Dickinson, Michael G.
Badings, Erik A.
Appelman, Yolande
van ’t Hof, Arnoud W. J.
ten Berg, Jurriën M.
Arslan, Fatih
Article History
Accepted: 13 August 2024
First Online: 10 September 2024
Conflict of interest
: B. Zwart has received speakers/consultancy fees from Bayer and AstraZeneca. B.E.P.M. Claessen has received honoraria from Abbott Vascular, Abiomed, Amgen, B. Braun, Boston Scientific, Philips and Sanofi for consultancy, speaking engagements and/or advisory board engagements. P. Damman has received research grants from Abbott, Philips, AstraZeneca and consultancy fees from Philips. P. Woudstra has received speakers fees from Philips and consultancy fees from Sanofi. Y. Appelman has received research grants from the Dutch Heart Foundation. In the past 36 months, A.W.J. van ’t Hof has received unrestricted grants from Abbott Vascular, Boehringer Ingelheim, Sanofi and consultancy fees from Celecor Therapeutics. J.M. ten Berg has received institutional research grants ZonMw, Daiichi Sankyo and advisor fees from CeleCor. M.A. Vink, J.W. Balder, M.G. Dickinson, E.A. Badings, and F. Arslan declare that they have no competing interests.